BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 30359322)

  • 1. Ceftriaxone-induced hemolytic anemia with severe renal failure: a case report and review of literature.
    Leicht HB; Weinig E; Mayer B; Viebahn J; Geier A; Rau M
    BMC Pharmacol Toxicol; 2018 Oct; 19(1):67. PubMed ID: 30359322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceftriaxone-Induced Hemolytic Anemia: A Rare Case Report.
    Kumar S; Bansal R; Bansal P; Dhamija RK; Neurology D
    Perm J; 2020; 24():. PubMed ID: 31905339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftriaxone-Induced Hemolytic Anemia in a Jehovah's Witness.
    Tasch J; Gonzalez-Zayaz P
    Am J Case Rep; 2017 Apr; 18():431-435. PubMed ID: 28428532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ceftriaxone-induced immune haemolytic anaemia and multi-organ failure].
    Mulkens CE; van Lochem EG; Folman CC; van der Spek E; van Leeuwen HJ
    Ned Tijdschr Geneeskd; 2015; 159():A8054. PubMed ID: 25714764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ceftriaxone-induced hemolytic anemia and hepatitis in an adolescent with hemoglobin SC disease.
    Bell MJ; Stockwell DC; Luban NL; Shirey RS; Shaak L; Ness PM; Wong EC
    Pediatr Crit Care Med; 2005 May; 6(3):363-6. PubMed ID: 15857541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftriaxone-induced hemolytic anemia: case report and review of literature.
    Northrop MS; Agarwal HS
    J Pediatr Hematol Oncol; 2015 Jan; 37(1):e63-6. PubMed ID: 24878619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftriaxone-induced immune hemolytic anemia.
    Neuman G; Boodhan S; Wurman I; Koren G; Bitnun A; Kirby-Allen M; Ito S
    Ann Pharmacother; 2014 Dec; 48(12):1594-604. PubMed ID: 25163809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftriaxone induced hemolysis complicated by acute renal failure.
    Kapur G; Valentini RP; Mattoo TK; Warrier I; Imam AA
    Pediatr Blood Cancer; 2008 Jan; 50(1):139-42. PubMed ID: 16602117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report: Decreased hemoglobin and multiple organ failure caused by ceftizoxime-induced immune hemolytic anemia in a Chinese patient with malignant rectal cancer.
    Lou C; Liu M; Ma T; Yang L; Long D; Li J; Lei H; Xiang D; Wang X; Li L; Cai X
    Front Immunol; 2024; 15():1390082. PubMed ID: 38756782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe drug-induced immune hemolysis due to ceftriaxone.
    Dara RC; Sharma R; Bhardwaj H
    Asian J Transfus Sci; 2020; 14(2):187-191. PubMed ID: 33767548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe ceftriaxone-induced hemolysis complicated by diffuse cerebral ischemia in a child with sickle cell disease.
    Schuettpelz LG; Behrens D; Goldsmith MI; Druley TE
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):870-2. PubMed ID: 19829151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing spectrum of drug-induced immune hemolytic anemia.
    Arndt PA; Garratty G
    Semin Hematol; 2005 Jul; 42(3):137-44. PubMed ID: 16041663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic characteristics of ceftriaxone antibodies in 25 patients with drug-induced immune hemolytic anemia.
    Arndt PA; Leger RM; Garratty G
    Transfusion; 2012 Mar; 52(3):602-12. PubMed ID: 21880048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone-related hemolysis and acute renal failure.
    Demirkaya E; Atay AA; Musabak U; Sengul A; Gok F
    Pediatr Nephrol; 2006 May; 21(5):733-6. PubMed ID: 16491410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ceftriaxone-induced hemolytic anemia in a child successfully managed with intravenous immunoglobulin.
    Vehapoğlu A; Göknar N; Tuna R; Çakır FB
    Turk J Pediatr; 2016; 58(2):216-219. PubMed ID: 27976566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular haemolysis in a patient on ceftriaxone with demonstration of anticeftriaxone antibodies.
    Dinesh D; Dugan N; Carter J
    Intern Med J; 2008 Jun; 38(6):438-41. PubMed ID: 18613898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune hemolytic anemia caused by drugs.
    Garratty G
    Expert Opin Drug Saf; 2012 Jul; 11(4):635-42. PubMed ID: 22502777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotetan-Induced Hemolytic Anemia: Case Series and Review.
    Lim K; Tran H; Hirai-Yang A; Vakil N; Marks G; Klapper E
    J Pharm Pract; 2019 Dec; 32(6):679-682. PubMed ID: 30189781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolytic anemia from ceftriaxone in an elderly patient: a case report.
    Imam SN; Wright K; Bhoopalam N; Choudhury A
    J Am Med Dir Assoc; 2008 Oct; 9(8):610-1. PubMed ID: 19083297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of immune hemolytic anemia induced by ceftizoxime and cefobactam (sulbactam/cefoperazone).
    Baek EJ; Lee S; Kim S; Choi HK; Kim HO
    Korean J Lab Med; 2009 Dec; 29(6):578-84. PubMed ID: 20046091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.